News of positive data from Moderna’s (Cambridge, MA) Phase I trial of a COVID-19 vaccine has dominated this week’s headlines. Their vaccine is an mRNA-based vaccine—an entirely new approach to not only vaccines but also to therapeutics. mRNA-based drugs...
Please enjoy this excerpt from our recently revised book, The Biotech Primer: An Insider’s Guide to the Science Driving the Biopharma Industry. This book explains the science behind the industry in an accessible manner, providing the foundation needed to...
About Biotech Primer
From startups to the Fortune 500, we train employees at companies of all sizes. We offer customized, in-house courses and open enrollment classes. Visit Biotech Primer for more information.
